News: Best postop treatment for stage III-IV endometriosis

Article

Following conservative pelvic surgery, hormonal suppression or dietary therapy are better than placebo at reducing pain and improving quality of live in women with stage III-IV endometriosis.

Following conservative pelvic surgery, hormonal suppression or dietary therapy are better than placebo at reducing pain and improving quality of life in women with stage III-IV endometriosis, according to the results of a randomized comparative trial involving 222 women.

The women were treated with either gonadotropin–releasing hormone analogue (GnRH-a) (tryptorelin or leuprorelin, 3.75 mg every 28 days); continuous estroprogestin (ethylnilestradiol, 0.03 mg plus gestoden 0.75 mg); a combination of vitamins, mineral salts, lactic ferments, and fish oil; or placebo.

At 1 year, the women treated with hormonal suppression showed greater improvement in visual analogue scale scores for dysmenorrhea than patients in the other groups, although the women receiving placebo also showed significant decreases in dyspareunia scores. Hormonal suppression and dietary therapy were equally effective in reducing nonmenstrual pelvic pain.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.